Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,623 signal articles · 85 in last 24h · 122,723 total before filter · latest 1h ago
85last 24h
1238last 7d
205● bullish (7d)
145● bearish (7d)
205publishers
AllMacro203Earnings415M&A100Regulatory24Product11Analyst10
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
What Does Red Cat Holdings (RCAT) Need To Prove After Its Latest Advances?
Simply Wall St.15d agoneutral
What Does Red Cat Holdings (RCAT) Need To Prove After Its Latest Advances?

Red Cat Holdings (NasdaqCM: RCAT) reports significant revenue and margin growth alongside progress in key defense and autonomy programs. The company advances to the final stages of a major U.S. military drone procurement process under the Drone Dominance program. Red Cat completes the acquisition of Quaze Technologies, adding new capabilities in autonomous platform technology. Subsidiary Blue Ops reaches a product integration milestone with Volvo Penta's marine propulsion system in the...

Warner Bros. Discovery (WBD) Wins UK Clearance For $110 Billion Takeover
Simply Wall St.15d agobullish
Warner Bros. Discovery (WBD) Wins UK Clearance For $110 Billion Takeover

Warner Bros. Discovery (NasdaqGS:WBD) is set to be acquired by Paramount in a $110b deal that has now received regulatory approval in the United Kingdom. The UK Competition and Markets Authority and the British culture secretary have cleared the transaction, removing one of the last major regulatory obstacles. This approval follows similar clearances in other major jurisdictions ahead of expected U.S. antitrust proceedings. The decision adds clarity for Warner Bros. Discovery investors,...

Celestica (TSX:CLS) Closes $3.45 Billion Equity Raise For AI Infrastructure Growth
Simply Wall St.15d agoneutral
Celestica (TSX:CLS) Closes $3.45 Billion Equity Raise For AI Infrastructure Growth

Celestica (TSX:CLS) completed a US$3.45b follow-on equity offering to support AI infrastructure growth. The sizeable capital raise expands Celestica's financial capacity for AI and data center networking projects. Proceeds are earmarked for capital investment and other initiatives tied to multi year demand in AI infrastructure. Consider broadening your research to other companies building out AI infrastructure through 55 AI infrastructure stocks TSX:CLS 1-Year Stock Price Chart Celestica...

Joby Aviation (JOBY) Is Up 20.8% After Raising 2026 Outlook And Expanding Texas Operations Hub
Simply Wall St.15d agoneutral
Joby Aviation (JOBY) Is Up 20.8% After Raising 2026 Outlook And Expanding Texas Operations Hub

In early August 2026, Joby Aviation reported second-quarter sales of US$38.64 million, raised its full-year 2026 revenue outlook to US$115 million–US$125 million, and expanded its US footprint with a new 45,000-square-foot facility at Perot Field Fort Worth Alliance Airport in Texas. Alongside a new vertiport development partnership with Atoms in key US markets, these moves highlight Joby’s push to pair eVTOL certification progress with real-world route infrastructure and operations through...

Amgen (AMGN) Stock Sees Fair Value Lift After Q2 Beat And Analyst Target Hikes
Simply Wall St.15d agobullish
Amgen (AMGN) Stock Sees Fair Value Lift After Q2 Beat And Analyst Target Hikes

Amgen is back in focus after updated valuation work lifted its modeled fair value from US$352.23 to US$371.93 per share, signaling a higher price target in the latest analyst run. Much of Wall Street commentary around this shift ties to recent Q2 beats, raised guidance, and differing views on how durable the current growth and pipeline story really is. As you read on, you will see how these moving pieces shape the evolving Amgen narrative and what to watch next in the research. Stay updated...

Blackstone (BX) Leads Kuwait Deal And AI Backing, Is The Upside Already Priced In?
Simply Wall St.15d agoneutral
Blackstone (BX) Leads Kuwait Deal And AI Backing, Is The Upside Already Priced In?

Blackstone (BX) is back in focus after leading a consortium in a $16,000 million lease and leaseback agreement with Kuwait Oil Company, alongside fresh backing of AI data center firm Firmus. See our latest analysis for Blackstone. The Kuwait Oil Company joint venture and the Firmus AI data center backing arrive as Blackstone’s share price trades at US$137.13, with a 30 day share price return of 15.60% and a year to date share price decline of 13.65%. Over longer periods, the stock’s 3 year...

Loar Q2 Earnings Call Highlights
MarketBeat15d agoneutral
Loar Q2 Earnings Call Highlights

Loar (NYSE:LOAR) reported record second-quarter sales, adjusted EBITDA and adjusted EBITDA margin, while raising its full-year 2026 outlook as commercial aerospace demand and organic business wins supported growth. Chief Executive Officer and Executive Co-Chairman Dirkson Charles said the quarter m

Xanadu Accelerates Chip Production as Investors Await Next Catalyst in Race to Scalable Quantum Computing – Quarterly Update Report
Exec Edge15d agoneutral
Xanadu Accelerates Chip Production as Investors Await Next Catalyst in Race to Scalable Quantum Computing – Quarterly Update Report

Download the Complete Report Here Xanadu Quantum Technologies (XNDU) Optical-Loss Progress and Higher Wafer Throughput Advance Hardware Roadmap as Growth Investment Accelerates Key Takeaways: XNDU advanced hardware execution, achieving 0.085 dB edge-coupling loss while increasing thin-film lithium niobate and silicon nitride fabrication by 75% and 50%. Higher wafer throughput accelerates qubit-factory iteration, with the aggregate […] The post Xanadu Accelerates Chip Production as Investors Awai

Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests – Quarterly Update Report
Exec Edge15d agoneutral
Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests – Quarterly Update Report

Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: International medical cannabis revenue increased 17% to C$43.3 million in 1Q FY27, reinforcing ACB’s leadership across global medical markets. Adjusted gross margin reached 58%, […] The post Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests

Sunrun (RUN) Stock Fair Value Falls As Analysts Weigh Growth Projects And Cash Risks
Simply Wall St.15d agobearish
Sunrun (RUN) Stock Fair Value Falls As Analysts Weigh Growth Projects And Cash Risks

Sunrun’s latest internal fair value estimate has shifted from US$18.84 to US$17.05, signaling a more conservative stance on the stock’s pricing. This reset lines up with recent Street research that balances enthusiasm for Sunrun’s grid scale storage and AI related projects with concerns about execution, cash generation, and sector level risks. As you read on, you will see how these moving pieces shape the evolving Sunrun narrative and what that can mean for your own view on the stock. Stay...

Hilton Worldwide Holdings (HLT) Could Be 9% Undervalued On Earnings And Buybacks
Simply Wall St.15d agobullish
Hilton Worldwide Holdings (HLT) Could Be 9% Undervalued On Earnings And Buybacks

Earnings, Dividend and Buyback Put Hilton Worldwide Holdings in Focus Hilton Worldwide Holdings (HLT) has drawn investor attention after reporting second quarter 2026 results, reaffirming its regular cash dividend and updating progress on a long running share repurchase program. For the second quarter ended June 30, 2026, Hilton Worldwide Holdings reported revenue of US$3,341 million compared with US$3,137 million a year earlier. Net income was US$482 million, with basic earnings per share...

Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?
Simply Wall St.15d agobullish
Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?

Halozyme earnings beat and guidance hike reshape the story Halozyme Therapeutics (HALO) just put fresh numbers on the table, reporting second quarter 2026 results, raising full year revenue guidance and updating progress on its share repurchase programs. For the quarter ended June 30, 2026, revenue was reported at US$481 million compared with US$325.72 million for the same period a year earlier. Net income for the quarter was US$229.91 million compared with US$165.16 million a year ago. Basic...